CEFASEL 200 nutri selenium tabs, 200 pcs

Instructions for use for the article Cefasel 200 nutri selenium tabs

Dietary supplements are not a substitute for a balanced, varied diet and a healthy lifestyle.No prescription is required for this product.

Sales name: dietary supplement.

Use/application/recommended consumption: Take one tablet daily without chewing with a little liquid, such as water.The recommended daily consumption amount should not be exceeded.

Storage conditions: Keep the product out of the reach of small children.

Nutritional declaration

Composition per daily dose (1 tablet) and the percentage of the recommended daily dose (NRV): Selenium 200 µg, which corresponds to 364% of the recommended daily dose. NRV stands for nutrient reference value according to the Food Information Ordinance (LMIV).

Ingredients

The ingredients include sugar, mannitol as a filler, polyvinylpyrrolidone as a solidifying agent, magnesium salts of fatty acids as an anti-caking agent and sodium selenite.

Allergens: Contains no allergens.

Net filling quantity: 57 g, corresponding to 200 tablets.

Country of origin of the food: Germany.

Manufacturer's address: Cefak KG, Ostbahnhofstraße 15, 87437 Kempten.

Further mandatory information

Selenium supports the normal function of the immune system and the thyroid.It contributes to the protection of cells from oxidative stress, the maintenance of normal hair and nails, and normal sperm formation.

Consuming sodium selenite and vitamin C at the same time should be avoided as this may affect the optimal availability of sodium selenite.However, staggered consumption (at least one hour) no longer has any influence.If consumed in excess, the product can have a laxative effect.

The product is 100% vegan and gluten-free.It contains no added lactose, gelatin, dyes, allergens, flavor or yeast.

Information from the shop editorial team: If you have any further questions about the information above, please contact our service hotline.

Source: Information from the manufacturer, as of: 02/2022.